1 ABSTRACT
Objective Correct use of face masks is required for their efficacy in preventing possible droplet infections with SARS-CoV-2. We tried to provide information about differences in the distribution of gender and age groups wearing face masks incorrectly.
Design Pilot field study
Methods Visual observation of mask use in public, not age- and gender-related places in central European large cities regarding incorrect mask-wearing (n=523); statistical analysis (nominal scale) in terms of gender and estimated age group using the total numbers, binomial test and chi-square test.
Results There is no significant difference (binomial test: p-value = 0.43) in mask misuse between the genders (female: 271 (51.8%), male: 252 (48.2%) and 0 non-binary individuals (0%)). There is a significant difference (chi-square test: p-value < 2.2e-16) in age group distribution (170 young 10-29 years (32.5%), 261 middle-aged 30-59 years (49.9%), 92 older adults ≥ 60 years (17.6%)). In total numbers, the highest counts were observed in middle-aged persons with 261 counts (49.9%).
Conclusion Our study shows an uneven age-distribution of people wearing the face mask in public improperly.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
There was no acquiring of personal data, so no conclusions on individuals can be drawn. Therefore, the University of Regensburg ethics committee saw a board review of our study as not obligatory.
Funding Statement
7 CONFLICT OF INTEREST All authors of this article certify that they have NO affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers' bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript. 8 ACKNOWLEDGMENTS We thank Florian Schlieckau, Simon Stelzl, Karl-Peter Ittner, Gerhard Hansch, and Fro Wirtz for helpful discussions
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
There was no acquiring of personal data, so no conclusions on individuals can be drawn. Therefore, the University of Regensburg ethics committee saw a board review of our study as not obligatory.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data that supports the findings of the study are available from the corresponding author, S.H., maskproject@gmx.de, upon reasonable request
